Bid Cap
Company library Industrials & Energy

Company report

Rocket Lab USA, Inc. RKLB

Three-pass checked

The bet you're really making is that Rocket Lab keeps launching its small Electron rockets reliably, and turns its big new rocket, Neutron, into a real business before it burns through its cash. You're betting the satellite-building side, now most of the money, keeps winning government and defense work. Right now sales are climbing fast, up 62% in a year to the largest quarter in the company's history, while it still loses money every quarter and is spending more, not less, to finish Neutron. You pay about 48 times a single year's sales for a company that has never turned a profit, near the richest it has been since it went public in 2020.

Key data

Price$64.26
52-week range$37.57 – $151
Price/sales, TTM48.4x
EV/sales, TTM45.8x

RKLB · price with moving averages

Daily · 6MWeekly · 3Y
$-8$33$74$114$155 Oct '23May '24Dec '24Jul '25Feb '26Oct '26 Bid Cap
EMAs82140

Source: market data.

The business

Rocket Lab does two things. It launches small satellites on its own Electron rocket, the only Western small-launch vehicle flying regularly besides SpaceX, at roughly $8M a mission. And it builds spacecraft and the parts that go inside them, solar panels, reaction wheels, flight computers, satellite buses, a business assembled through acquisition that is now the larger share of revenue and sells mostly to government and defense customers. Stitched over both is Neutron, a medium-lift rocket meant to carry 8-ton payloads and compete with SpaceX's Falcon 9, still in development and not yet flown. The moat, such as it is, is being the number-two Western launch provider and owning the satellite componentry underneath a national-security supply chain that Washington wants to keep off a single vendor. What you are actually buying is a manufacturer, not a launch company: the rockets get the headlines, the satellite factory pays more of the bills.

The numbers

The last five quarters show a business scaling hard on the top line and standing still on the bottom.

QuarterRevenueNet incomeDiluted EPS
Q2 2025$144.5M-$66.4M-$0.13
Q3 2025$155.1M-$18.3M-$0.03
Q4 2025$179.7M-$52.9M-$0.09
Q1 2026$200.3M-$45.0M-$0.07
Q2 2026$234.1M-$49.3M-$0.08

Revenue grew every quarter and landed 62% above a year ago. Do not read the shrunken Q3 2025 loss as progress: a $41M tax benefit did that, not operations. The honest sequence is that the net loss sat between $45M and $66M the whole way while sales rose by two thirds. The half of the recent story that said losses narrow every quarter did not survive the last two prints: the operating loss has held near $55M for four straight quarters even as revenue climbed, because Neutron spending is rising as fast as gross profit.

YearRevenueNet incomeDiluted EPS
2021$62.2M-$117.3M-$0.26
2022$211.0M-$135.9M-$0.29
2023$244.6M-$182.6M-$0.38
2024$436.2M-$190.2M-$0.38
2025$601.8M-$198.2M-$0.37
2026, 1H to Jun$434.4M-$94.3M-$0.15

Revenue is up almost ten times in four years, a 42% compound rate over the last three. The loss grew with it, and the cash statement is the part that bites: free cash flow was -$322M in 2025, worse than the -$116M of 2024, as capex to build Neutron doubled. That burn is funded, not solved. The company holds about $2.3B in cash, a current ratio of 5.5 and almost no debt, but it got there by printing shares: the count rose from 466M in 2022 to 630M today, up 35%. At the current pace of loss the balance sheet buys several years, unless Neutron capex accelerates, which is exactly what management says it will do.

QuarterRevenueGross marginOperating loss
Q2 2025$144.5M32.1%-$59.6M
Q3 2025$155.1M37.0%-$59.0M
Q4 2025$179.7M38.0%-$51.0M
Q1 2026$200.3M38.2%-$56.0M
Q2 2026$234.1M36.1%-$57.5M

Here is the whole argument in one table. Gross margin climbed from 32% to the high 30s as the satellite business scaled, and operating loss as a share of revenue improved from -41% to -25%. But the dollar loss never fell, because every dollar of new gross profit went straight back out as research and Neutron overhead. What this memo believes that the tape does not: the existing Electron-plus-satellites business is quietly approaching its own breakeven, separate from the Neutron lottery ticket, and the first successful Neutron flight is the print that either confirms a second Western medium-lift provider or exposes how much of the price was a rocket that had not launched.

Management

Sir Peter Beck founded this and still runs it, and the alignment reads two ways at once. His cash pay is modest, under $1M in the last disclosed year, and the founder stake is the real incentive. But over the last twelve months insiders sold $356M of stock across 85 sales and bought nothing, with Beck himself disposing of about $96M in two days in early July. The data here does not show whether those sales ran on a scheduled 10b5-1 plan or were discretionary, and that distinction is the difference between routine diversification and a signal, so it is worth reading the Form 4 before weighting it. The company did repurchase $30M of stock in 2021 but has not bought back a share since; this is a business that funds growth with equity, not cash returned.

How it fails or surprises you

Neutron lands and re-rates the whole company (right tail). The market pays today mostly for Electron economics and a satellite factory. If Neutron flies successfully in the next year and wins a national-security launch slot at a price that undercuts Falcon 9, the story converts from small-launch niche to credible number-two heavy provider, a market measured in billions. The print: a clean first orbital flight plus a signed launch contract.

Neutron slips and the raise comes at a lower price. Operating loss has held near $55M a quarter while free-cash burn accelerated to $322M a year. A multi-quarter Neutron delay pushes breakeven past the comfortable part of the cash pile and forces another equity raise, diluting holders again after 35% already. The print: a pushed Neutron date on the next call, or capex guidance stepped up.

The leverage that is not showing up in dollars. Revenue grew 62% and the absolute loss did not shrink at all. If operating leverage were as real as the margin percentages imply, the dollar loss should be falling; instead overhead is eating the gains. The print: whether Q3 2026 operating loss breaks below $50M or stays above it on flat revenue growth.

Closing thoughts

The first Neutron flight, expected inside the next year, either settles the valuation or defers it. Land the rocket and win a national-security launch slot, and the price that looks absurd on sales becomes a down payment on a second launch franchise; miss it or slip the date again, and you own a small-launch company with a satellite arm, burning $300M a year, priced at 48 times sales. An ambiguous print, a partial flight or a slipped-but-alive schedule, keeps the burn running and the raise looming, and the reader who cannot stomach another dilution should treat that as the exit, not the entry. The left tail is fatter than the enthusiasm allows, because the thing that fails first, the cash, is the thing the excitement ignores.

The bet is still that Rocket Lab keeps launching its small Electron rockets reliably and turns its big new rocket, Neutron, into a real business before it burns through its cash, and that the satellite-building side keeps winning government and defense work. What breaks it is a Neutron slip against a burn that is not slowing, and the one pair of numbers that tells you first is the quarterly operating loss set against the cash balance: the day the loss stops falling as a share of revenue while cash drops below two years of runway, the story has changed regardless of what the rocket does next.

Methodology

Sector frame per the company's own filings. Anchored to the most recent Form 10-Q and 10-K on EDGAR as of Sep 6, 2026, with income, balance sheet and cash flow figures taken as filed.

Price, 52-week range and multiples are vendor market data as of Sep 6, 2026; the valuation shown is price and enterprise value to sales because the company has no earnings to price.

Quarterly year-over-year sequences and any figure described as derived are computed from as-filed data and labelled where they appear.

Items the filings do not disclose, including the 10b5-1 status of insider sales, are stated as not disclosed rather than estimated.

Documentation prepared with AI assistance. Not investment advice.

Fact check: Q1 2026 operating table row corrected (revenue $200.3M not $234.1M, margin 38.2% not 36.1%, operating loss -$56.0M not -$57.5M); Q2 2026 row added; 2021 buyback noted in management section. All bundle financials reconciled to FMP. Final analysis verified as of Sep 6, 2026.

Bid Cap

Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.

Subscribe on Substack